Who Buys Lenvatinib from India — 242 Importers Behind a $2.1M Market
India's lenvatinib import market is served by 242 active buyers who collectively imported $2.1M across 863 shipments. LEK PHARMACEUTICALS D D (SLOVENIA) leads with a 11.9% market share, followed by STR INTERNATIONAL TRADING CO., LTD and STR INTERNATIONAL TRADING CO LTD.. The top 5 buyers together control 22.0% of total import value, reflecting a moderately competitive buyer landscape.
Lenvatinib buyer data — 242 importers · $2.1M market · 863 shipmentsTransData Nexus · Indian Customs Data
Top Lenvatinib Importers — Ranked by Import Value
LEK PHARMACEUTICALS D D (SLOVENIA) is the leading lenvatinib importer from India, holding a 11.9% share of the $2.1M market across 863 shipments from 242 buyers. The top 5 buyers — LEK PHARMACEUTICALS D D (SLOVENIA), STR INTERNATIONAL TRADING CO., LTD (THAILAND), STR INTERNATIONAL TRADING CO LTD. (THAILAND), LEK PHARMACEUTICALS D.D. (SLOVENIA), TOROPH (KAZAKHSTAN) — collectively control 22.0% of total import value.
Top Lenvatinib Buyers & Importers
Ranked by import value · 242 active buyers · Indian Customs (DGFT) data
Mar 2026
Top Lenvatinib Buyers & Importers — Ranked by Import Value. 242 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
Which companies are buying Lenvatinib — and from which countries?
Flow of Lenvatinib exports from India: each country's share and the named importers behind the numbers
Lenvatinib — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Top 5 importing countries account for 69.9% of global Lenvatinib imports — led by Brazil (38.3%) with a total trade value of $2.1M across 863 shipments from India.
Market Analysis: Top Importing Countries & Their Importers
1Brazil
Brazil emerges as the first largest importing country, achieving a total trade value of $815.6K through 6 shipments. This represents a market share of 38.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Brazil has a diverse importer base, with their top importers including:
• `TO THE ORDER OF - $22.6K (2.8% of country's total business)
Key Insight: Brazil demonstrates strong market positioning with an average shipment value of $135.9K, indicating premium pricing strategy compared to the market average of $2.5K.
Brazil is a key market for Lenvatinib imports, representing 38.3% of total trade value.
Primary Market
Secondary Market
2Slovenia
Slovenia emerges as the second largest importing country, achieving a total trade value of $311.6K through 31 shipments. This represents a market share of 14.6% of the total market activity, demonstrating their significant presence in the industry.
Slovenia has a diverse importer base, with their top importers including:
The importation of Lenvatinib from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like STR International Trading Co., Ltd. in Thailand function as intermediaries, procuring Lenvatinib in bulk to supply to healthcare providers and pharmacies. Their purchasing patterns are characterized by large, regular orders to maintain a steady supply chain.
Hospital Groups: Organizations such as LEK Pharmaceuticals D.D. in Slovenia represent hospital networks that import Lenvatinib directly for patient treatment. Their procurement is typically based on patient demand and treatment protocols, leading to consistent, volume-based orders.
Re-exporters: Companies like Radeep Services in Singapore may act as re-exporters, importing Lenvatinib for redistribution to neighboring regions. Their buying behavior is influenced by regional demand fluctuations, resulting in variable order sizes and frequencies.
Government Procurement: Entities such as "To the Import Manager" in the United Arab Emirates likely represent government procurement agencies responsible for national healthcare supplies. Their purchasing is often conducted through formal tenders, focusing on large-scale, cost-effective procurement to meet public health needs.
Importing Lenvatinib into the top five importing countries involves navigating specific regulatory frameworks:
Brazil:
Regulatory Authority: Agência Nacional de Vigilância Sanitária (ANVISA).
Import Registration Process: Requires submission of a comprehensive dossier, including clinical data and manufacturing details, followed by ANVISA's evaluation.
Estimated Timeline: Approximately 6 to 12 months, depending on dossier completeness and ANVISA's review capacity.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are subject to a standard import duty of 8%, with potential reductions under specific trade agreements.
Slovenia:
Regulatory Authority: Javna Agencija Republike Slovenije za Zdravila in Medicinske Pripomočke (JAZMP).
The demand for Lenvatinib across importing countries is influenced by several key factors:
Disease Prevalence: Lenvatinib is primarily used in the treatment of various cancers, including thyroid, renal cell, and hepatocellular carcinomas. The prevalence of these cancers in importing countries directly impacts demand. For instance, the increasing incidence of thyroid cancer globally has heightened the need for effective treatments like Lenvatinib.
Government Healthcare Programs: Many countries have implemented healthcare initiatives aimed at improving cancer care. Programs that subsidize or fully cover the cost of essential medicines enhance patient access to treatments like Lenvatinib.
Universal Health Coverage Expansion: Efforts to achieve universal health coverage (UHC) have led to increased inclusion of cancer treatments in national health insurance schemes, thereby boosting demand for Lenvatinib.
WHO Essential Medicines List Procurement: Inclusion of cancer treatments in the WHO Essential Medicines List encourages countries to prioritize their procurement, ensuring broader access.
Common Questions — Lenvatinib Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest lenvatinib buyer importing from India?
Based on import volume and value, LEK PHARMACEUTICALS D D (SLOVENIA) leads with $253.3K in imports and a 11.9% market share — the highest of any single lenvatinib importer. STR INTERNATIONAL TRADING CO., LTD (THAILAND) and STR INTERNATIONAL TRADING CO LTD. (THAILAND) are the next largest buyers.
QHow many companies buy lenvatinib from India?
There are 242 active lenvatinib buyers importing from India, with a combined market of $2.1M across 863 shipments to 74 countries. The top 5 buyers hold 22.0% of total import value, while the remaining 237 buyers handle the other 78.0%.
QWhich countries import the most lenvatinib from India?
The top importing countries for lenvatinib from India are Brazil (38.3%), Slovenia (14.6%), Thailand (6.8%), United Arab Emirates (6.2%), Singapore (4.0%). These markets represent the largest demand centres for Indian pharmaceutical exports of lenvatinib, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for lenvatinib from India?
The average import transaction value for lenvatinib from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
The importation of Lenvatinib from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like STR International Trading Co., Ltd. in Thailand function as intermediaries, procuring Lenvatinib in bulk to supply to healthcare providers and pharmacies. Their purchasing patterns are characterized by large, regular orders to maintain a steady supply chain.
Hospital Groups: Organizations such as LEK Pharmaceuticals D.D. in Slovenia represent hospital networks that import Lenvatinib directly for patient treatment. Their procurement is typically based on patient demand and treatment protocols, leading to consistent, volume-based orders.
Re-exporters: Companies like Radeep Services in Singapore may act as re-exporters, importing Lenvatinib for redistribution to neighboring regions. Their buying behavior is influenced by regional demand fluctuations, resulting in variable order sizes and frequencies.
Government Procurement: Entities such as "To the Import Manager" in the United Arab Emirates likely represent government procurement agencies responsible for national healthcare supplies. Their purchasing is often conducted through formal tenders, focusing on large-scale, cost-effective procurement to meet public health needs.
Importing Lenvatinib into the top five importing countries involves navigating specific regulatory frameworks:
Brazil:
Regulatory Authority: Agência Nacional de Vigilância Sanitária (ANVISA).
Import Registration Process: Requires submission of a comprehensive dossier, including clinical data and manufacturing details, followed by ANVISA's evaluation.
Estimated Timeline: Approximately 6 to 12 months, depending on dossier completeness and ANVISA's review capacity.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are subject to a standard import duty of 8%, with potential reductions under specific trade agreements.
Slovenia:
Regulatory Authority: Javna Agencija Republike Slovenije za Zdravila in Medicinske Pripomočke (JAZMP).
The demand for Lenvatinib across importing countries is influenced by several key factors:
Disease Prevalence: Lenvatinib is primarily used in the treatment of various cancers, including thyroid, renal cell, and hepatocellular carcinomas. The prevalence of these cancers in importing countries directly impacts demand. For instance, the increasing incidence of thyroid cancer globally has heightened the need for effective treatments like Lenvatinib.
Government Healthcare Programs: Many countries have implemented healthcare initiatives aimed at improving cancer care. Programs that subsidize or fully cover the cost of essential medicines enhance patient access to treatments like Lenvatinib.
Universal Health Coverage Expansion: Efforts to achieve universal health coverage (UHC) have led to increased inclusion of cancer treatments in national health insurance schemes, thereby boosting demand for Lenvatinib.
WHO Essential Medicines List Procurement: Inclusion of cancer treatments in the WHO Essential Medicines List encourages countries to prioritize their procurement, ensuring broader access.
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Top Importers:
• LEK PHARMACEUTICALS D D - $253.3K (81.3% of country's total business)
• LEK PHARMACEUTICALS D.D. - $51.5K (16.5% of country's total business)
Key Insight: Slovenia demonstrates strong market positioning with an average shipment value of $10.1K, indicating premium pricing strategy compared to the market average of $2.5K.
Slovenia is a key market for Lenvatinib imports, representing 14.6% of total trade value.
Primary Market
Secondary Market
3Thailand
Thailand emerges as the third largest importing country, achieving a total trade value of $145.2K through 27 shipments. This represents a market share of 6.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Thailand has a diverse importer base, with their top importers including:
• STR INTERNATIONAL TRADING CO., LTD - $63.9K (44.0% of country's total business)
• STR INTERNATIONAL TRADING CO LTD. - $51.7K (35.6% of country's total business)
• STR INTERNATIONAL TRADING CO LTD - $38.9K (26.8% of country's total business)
Key Insight: Thailand demonstrates strong market positioning with an average shipment value of $5.4K, indicating premium pricing strategy compared to the market average of $2.5K.
Thailand is a key market for Lenvatinib imports, representing 6.8% of total trade value.
Primary Market
Secondary Market
4United Arab Emirates
United Arab Emirates emerges as the fourth largest importing country, achieving a total trade value of $132.0K through 11 shipments. This represents a market share of 6.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United Arab Emirates has a diverse importer base, with their top importers including:
• TO THE IMPORT MANAGER - $44.1K (33.4% of country's total business)
Key Insight: United Arab Emirates demonstrates strong market positioning with an average shipment value of $12.0K, indicating premium pricing strategy compared to the market average of $2.5K.
United Arab Emirates is a key market for Lenvatinib imports, representing 6.2% of total trade value.
Primary Market
Secondary Market
5Singapore
Singapore emerges as the fifth largest importing country, achieving a total trade value of $85.0K through 23 shipments. This represents a market share of 4.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Singapore has a diverse importer base, with their top importers including:
• RADEEP SERVICES - $26.7K (31.4% of country's total business)
• FREIGHT LINKS EXPRESS PTE LTD - $19.4K (22.9% of country's total business)
Key Insight: Singapore demonstrates strong market positioning with an average shipment value of $3.7K, indicating premium pricing strategy compared to the market average of $2.5K.
Singapore is a key market for Lenvatinib imports, representing 4.0% of total trade value.
Primary Market
Secondary Market
Understanding these segments is crucial for tailoring market strategies, ensuring efficient supply chain management, and meeting the specific needs of each buyer category.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Involves submission of an application with supporting documents, including quality, safety, and efficacy data, for JAZMP's assessment.
Estimated Timeline: Typically 6 to 9 months, subject to the complexity of the application and JAZMP's workload.
Import Tariff/Duty: As an EU member, Slovenia applies the EU's Common External Tariff, generally 0% for pharmaceutical products under HS Code 30049099.
Thailand:
Regulatory Authority: Thai Food and Drug Administration (Thai FDA).
Import Registration Process: Requires submission of a registration dossier, including product specifications and clinical data, followed by Thai FDA's evaluation.
Estimated Timeline: Approximately 8 to 12 months, depending on the completeness of the submission and regulatory review processes.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are generally subject to an import duty of 0%, promoting access to essential medicines.
United Arab Emirates (UAE):
Regulatory Authority: Ministry of Health and Prevention (MOHAP).
Import Registration Process: Involves submission of an application with detailed product information, including manufacturing and clinical data, for MOHAP's review.
Estimated Timeline: Typically 6 to 9 months, contingent on the application's complexity and MOHAP's review schedule.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are generally exempt from import duties, facilitating access to essential medicines.
Singapore:
Regulatory Authority: Health Sciences Authority (HSA).
Import Registration Process: Requires submission of a registration dossier, including quality, safety, and efficacy data, followed by HSA's evaluation.
Estimated Timeline: Approximately 9 to 12 months, depending on the completeness of the submission and HSA's review processes.
Import Tariff/Duty: Singapore imposes a 0% import duty on pharmaceutical products under HS Code 30049099, supporting the availability of essential medicines.
Navigating these regulatory landscapes is essential for successful market entry and sustained supply of Lenvatinib in these regions.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Government and institutional tenders for bulk purchasing of pharmaceuticals often include Lenvatinib, reflecting its recognized therapeutic value and driving substantial demand.
With 242 buyers across 74 countries, the global reach of Lenvatinib underscores its critical role in cancer treatment and the importance of understanding these demand drivers to effectively address market opportunities.
TransData Nexus Research · Government and regulatory sourcesMar 2026
$2.5K
$95.11 per unit
Understanding these segments is crucial for tailoring market strategies, ensuring efficient supply chain management, and meeting the specific needs of each buyer category.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Involves submission of an application with supporting documents, including quality, safety, and efficacy data, for JAZMP's assessment.
Estimated Timeline: Typically 6 to 9 months, subject to the complexity of the application and JAZMP's workload.
Import Tariff/Duty: As an EU member, Slovenia applies the EU's Common External Tariff, generally 0% for pharmaceutical products under HS Code 30049099.
Thailand:
Regulatory Authority: Thai Food and Drug Administration (Thai FDA).
Import Registration Process: Requires submission of a registration dossier, including product specifications and clinical data, followed by Thai FDA's evaluation.
Estimated Timeline: Approximately 8 to 12 months, depending on the completeness of the submission and regulatory review processes.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are generally subject to an import duty of 0%, promoting access to essential medicines.
United Arab Emirates (UAE):
Regulatory Authority: Ministry of Health and Prevention (MOHAP).
Import Registration Process: Involves submission of an application with detailed product information, including manufacturing and clinical data, for MOHAP's review.
Estimated Timeline: Typically 6 to 9 months, contingent on the application's complexity and MOHAP's review schedule.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are generally exempt from import duties, facilitating access to essential medicines.
Singapore:
Regulatory Authority: Health Sciences Authority (HSA).
Import Registration Process: Requires submission of a registration dossier, including quality, safety, and efficacy data, followed by HSA's evaluation.
Estimated Timeline: Approximately 9 to 12 months, depending on the completeness of the submission and HSA's review processes.
Import Tariff/Duty: Singapore imposes a 0% import duty on pharmaceutical products under HS Code 30049099, supporting the availability of essential medicines.
Navigating these regulatory landscapes is essential for successful market entry and sustained supply of Lenvatinib in these regions.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Government and institutional tenders for bulk purchasing of pharmaceuticals often include Lenvatinib, reflecting its recognized therapeutic value and driving substantial demand.
With 242 buyers across 74 countries, the global reach of Lenvatinib underscores its critical role in cancer treatment and the importance of understanding these demand drivers to effectively address market opportunities.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Analysis Methodology
1.Buyer Identification: 242 global importers of Lenvatinib identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 863 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 74 destination countries with market share per buyer calculated from capped values.
